Hepatic Steatosis (Fatty Liver Disease)

Last November, I posted this note - re a fatty liver research project being funded by EMV - on the 'Emvision Research Notes' thread:

Electromagnetic Scanner for Hepatic Steatosis Detection, Classification and Monitoring (2021–2022)

Grant type:
EMvision Medical Devices Ltd
Researchers:

• 
  Professor Amin Abbosh
  Professor
  School of Information Technology and Electrical Engineering
  Faculty of Engineering, Architecture and Information Technology
• 
  Dr Sasan Ahdi Rezaeieh
  UQ Amplify Lecturer
  School of Information Technology and Electrical Engineering
  Faculty of Engineering, Architecture and Information Technology

Funded by:
EMvision Medical Devices Ltd

Given some exciting research status news out of this UQ/EMV partnership this week, I think this project warrants a separate thread.

The research update is authored by the inventor of EMV's tech, Professor Amin Abbosh and includes EMV's Algorithm Engineer, Mojtaba Khosravi-Farsani, on the team.

Fatty Liver Disease is huge - with 25% of the US population affected.

Based on the interim results and comparisons with Ultrasound and CT - see Conclusion below - the early detection of FLD via this electro-magnetic imaging could be a potential game changer:


VI. CONCLUSION

An effective permittivity estimation method, applicable to a multilayer and heterogeneous medium, such as the human torso, is proposed. Unlike previous techniques, the proposed method does not require any training process or large number of antennas around the domain. It can estimate the dispersive effective permittivity of each side of the torso and find the left/right contrast in permittivity.

The method can differentiate steatotic livers from healthy ones by their higher permittivity contrast. Additionally, the method is robust to different body structures and small errors in antenna positioning.

Its capability for clinical application is also verified via human tests.

Unlike, US and CT devices which cannot detect mild HS stage with less than 33% diffused fat, the proposed method is able to detect mild steatotic livers with only 15% diffused fat

https://www.researchgate.net/public...Contrast_in_Effective_Dispersive_Permittivity